Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bone marrow mesenchymal stem cell transplantation versus autologous bone marrow mononuclear cell transplantation for cerebral palsy
ChiCTR-TRC-12002568Phase 2Completed
- Sponsor
- The Third Medical Center of the Chinese People's Liberation Army General Hospital
- Start
- May 2010
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous bone-marrow mesenchymal stem cells and autologous bone marrow-derived mononuclear cell in cerebral palsy (CP) (3 arms), sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoint: GMFM score. Started May 2010; status: completed.
02
Drugs
autologous bone-marrow mesenchymal stem cellsautologous bone marrow-derived mononuclear cell
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on ChiCTR-TRC-12002568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002568.